The efficacy and adverse events of bevacizumab combined with temozolomide in the treatment of glioma: a systemic review and meta-analysis of randomized controlled trials

ObjectivesTo assess the efficacy and adverse events of bevacizumab (BEV) combined with temozolomide (TMZ) in the treatment of glioma.Materials and methodsRandomized controlled trials (RCT) involving BEV combined with TMZ in the treatment of glioma were searched using PubMed, Embase and Cochrane libr...

Full description

Bibliographic Details
Published in:Frontiers in Medicine
Main Authors: SiYao Wei, LanYin Chang, Yi Zhong
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-07-01
Subjects:
glioma
bevacizumab
temozolomide
efficacy
adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1419038/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2024.1419038/full

Similar Items